Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites

The presence, pharmacological properties and anatomical distribution of serotonin-1A and serotonin-1B receptor subtypes were studied in the human brain by both radioligand binding assays and autoradiographic procedures. Frontal cortices and hippocampi from human brains obtained at autopsy without evidence of neurological disease were used in this study. [3H]5-HT was used to label both 5-HT1A and 5-HT1B receptor subtypes. 5-HT1A receptors were selectively labeled by [3H]8-hydroxy-2[di-N-propylamino]tetralin, while 5-HT1B receptors were labeled by (-)-[125I]iodocyanopindolol ([125I]CYP) in the presence of 30 microM isoprenaline. The pharmacological profile of 5-HT1A receptors in human brain tissue was very similar to those previously found in rat and pig brain tissues. The general anatomical distribution of these sites was also similar to that found in the rat brain, although some differences were observed when analyzed at the microscopic level. In contrast to 5-HT1A receptors, it was not possible to identify 5-HT receptors having the pharmacological properties of 5-HT1B sites in the human brain, using either [3H]5-HT or [125I]CYP as ligands. The absence of identifiable 5-HT1B receptors in human brain preparations, a fact previously found in pig brain tissue, is discussed in terms of the existence of species differences in brain serotonin receptors.

[1]  J. Glowinski,et al.  Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT , 1983, Nature.

[2]  J. Palacios,et al.  Multiple opiate receptor in human brain: an autoradiographic investigation. , 1983, Life sciences.

[3]  A. Frazer,et al.  Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex. , 1984, Molecular pharmacology.

[4]  R. Lefkowitz,et al.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.

[5]  J. Palacios,et al.  Distribution of α2-adrenergic receptors in the human brainstem: An autoradiographic study using [3H]p-aminoclonidine , 1984 .

[6]  R. Schnellmann,et al.  3H-serotonin binding sites: pharmacological and species differences. , 1983, Advances in biochemical psychopharmacology.

[7]  F. Artaud,et al.  Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. , 1984, European journal of pharmacology.

[8]  M. Hamon,et al.  [3H]8‐Hydroxy‐2‐(Di‐n‐Propylamino)Tetralin Binding to Pre‐ and Postsynaptic 5‐Hydroxytryptamine Sites in Various Regions of the Rat Brain , 1985, Journal of neurochemistry.

[9]  D. Middlemiss,et al.  8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. , 1983, European journal of pharmacology.

[10]  I. Creese,et al.  Neurotransmitter receptor binding: regional distribution in human brain , 1977, Journal of neurochemistry.

[11]  J. Leysen,et al.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.

[12]  S H Snyder,et al.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.

[13]  D. Hoyer,et al.  Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. , 1985, European journal of pharmacology.

[14]  D Rodbard,et al.  Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. , 1974, Clinical chemistry.

[15]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[16]  J. Palacios,et al.  The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. , 1984, European journal of pharmacology.

[17]  H. Yamamura,et al.  Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain , 1981, Journal of neurochemistry.

[18]  J. Palacios,et al.  Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites , 1986, Brain Research.

[19]  J. Palacios,et al.  β-Adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain , 1985, Brain Research.

[20]  Michael J. Kuhar,et al.  Quantitative receptor autoradiography using [3H]Ultrofilm: application to multiple benzodiazepine receptors , 1982, Journal of Neuroscience Methods.

[21]  J. Palacios,et al.  The distribution of serotonin receptors in the human brain: high density of [3H]LSD binding sites in the raphe nuclei of the brainstem , 1983, Brain Research.

[22]  S. Snyder,et al.  Serotonin receptor binding sites affected differentially by guanine nucleotides. , 1979, Molecular pharmacology.

[23]  L. Iversen,et al.  Human Brain Postmortem Studies of Neurotransmitters and Related Markers , 1982 .

[24]  I. Lucki,et al.  Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. , 1984, The Journal of pharmacology and experimental therapeutics.

[25]  D. Taylor,et al.  Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat , 1983, Neuropharmacology.

[26]  J. Boissier,et al.  Biochemical assessment of the central 5-HT agonist activity of RU 24969 (a piperidinyl indole). , 1980, European journal of pharmacology.

[27]  J. Deniau,et al.  Decrease of [3H]5‐HT high affinity binding and 5‐HT adenylate cyclase activation after kainic acid lesion in rat brain striatum , 1979, Journal of neurochemistry.

[28]  H. Weinstein,et al.  Two 5-HT receptors linked to adenylate cyclase in guinea pig hippocampus are discriminated by 5-carboxamidotryptamine and spiperone. , 1985, European journal of pharmacology.

[29]  J. Palacios,et al.  Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. , 1984, European journal of pharmacology.

[30]  K. O'Shaughnessy,et al.  Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone , 1983, Neuropharmacology.

[31]  S. Snyder,et al.  Neurotransmitter receptors in frontal cortex of schizophrenics. , 1979, Archives of general psychiatry.

[32]  J. Palacios,et al.  Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: Brainstem , 1984, Neuroscience.

[33]  D. Middlemiss,et al.  Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor , 1977, Nature.

[34]  D. Hoyer,et al.  Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol. , 1985, European journal of pharmacology.

[35]  C. Oberlander,et al.  The interaction of indole derivatives with the serotonin receptor and non-dopaminergic circling behaviour. , 1981, Advances in experimental medicine and biology.

[36]  S. Nahorski,et al.  Binding of 125I-iodohydroxybenzylpindolol to cerebral membranes: association with 5-hydroxytryptamine recognition sites as well as beta-adrenoceptors. , 1983, Biochemical pharmacology.

[37]  M. Hamon,et al.  Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain , 1984, Brain Research.

[38]  E. Schlicker,et al.  Serotonin release in human cerebral cortex and its modulation via serotonin receptors , 1985, Brain Research.

[39]  P. Janssen,et al.  The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: Antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist , 1983, Neuropharmacology.

[40]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[41]  E. Schlicker,et al.  Autoreceptor-mediated inhibition of 3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine. , 1983, Life sciences.

[42]  T. Crow,et al.  Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides , 1984, Neuropharmacology.

[43]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[44]  A. Cross.  Interactions of [3H]LSD with serotonin receptors in human brain. , 1982, European journal of pharmacology.

[45]  J. Maloteaux,et al.  Characterization and regional distribution of serotonin S2-receptors in human brain , 1983, Brain Research.

[46]  H. Yamamura,et al.  Computer-assisted autoradiographic localization of subtypes of serotonin1 receptors in rat brain , 1983, Brain Research.